News

Updates from NHS BSA, MHRA drug safety alerts, and other medical news.

Deuruxolitinib added to NHS dm+d 6.1.0 — key information for event medics

Deuruxolitinib: a new entry in the dm+d dictionary The NHS Business Services Authority has added deuruxolitinib to the dm+d (dictionary of medicines and devices) in version 6.1.0. Deuruxolitinib is a selective Janus kinase (JAK) inhibitor — a class of targeted immunosuppressant drugs. What is it used for? Deuruxolitinib is indicated for the treatment of atopic […]